Erzhi Tiangui Granule

Developed for: female infertility
Investigated by: 960th Hospital of Joint Logistics Support Force of People's Liberation Army of China · Chongqing Medical Center for Women and Children · First Affiliated Hospital of Wenzhou Medical University · Maternal and Child Health Care Hospital of Shandong Province · Maternity and Child Health Care of Zaozhuang · Shandong University
+4 more
· Shandong University of Traditional Chinese Medicine · Shanxi Provincial Maternity and Children's Hospital · The Second Hospital of Hebei Medical University · Yantai Shan Hospital

202420252026

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
—	NCT05698550	Sep 2023 → Jun 2025	female infertility	Shandong University of Traditional Chinese Medicine	Completed	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	Erzhi Tiangui Granule	ClinicalTrials.gov intervention name — accepted as the source's own label NCT05698550 ↗
Route	Oral	“The EZTG or placebo was orally administered after being dissolved in water” NCT05698550 ↗